Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8445 | 1183 | 38.1 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2118 | 4652 | BINUCLEATED LYMPHOCYTES//HUMANIZED MICE//CHEMOSENSITIVITY TEST |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HUMANIZED MICE | Author keyword | 36 | 45% | 5% | 61 |
2 | HU PBL SCID | Author keyword | 22 | 81% | 1% | 13 |
3 | SCID MOUSE | Author keyword | 14 | 23% | 5% | 55 |
4 | SCID MICE | Author keyword | 13 | 17% | 6% | 72 |
5 | RAG HU MICE | Author keyword | 6 | 100% | 0% | 4 |
6 | NOG MICE | Author keyword | 5 | 41% | 1% | 9 |
7 | NOG MOUSE | Author keyword | 5 | 55% | 1% | 6 |
8 | HUMANIZED MOUSE | Author keyword | 4 | 29% | 1% | 13 |
9 | BLT MICE | Author keyword | 4 | 67% | 0% | 4 |
10 | ASIALO GM 1 | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HUMANIZED MICE | 36 | 45% | 5% | 61 | Search HUMANIZED+MICE | Search HUMANIZED+MICE |
2 | HU PBL SCID | 22 | 81% | 1% | 13 | Search HU+PBL+SCID | Search HU+PBL+SCID |
3 | SCID MOUSE | 14 | 23% | 5% | 55 | Search SCID+MOUSE | Search SCID+MOUSE |
4 | SCID MICE | 13 | 17% | 6% | 72 | Search SCID+MICE | Search SCID+MICE |
5 | RAG HU MICE | 6 | 100% | 0% | 4 | Search RAG+HU+MICE | Search RAG+HU+MICE |
6 | NOG MICE | 5 | 41% | 1% | 9 | Search NOG+MICE | Search NOG+MICE |
7 | NOG MOUSE | 5 | 55% | 1% | 6 | Search NOG+MOUSE | Search NOG+MOUSE |
8 | HUMANIZED MOUSE | 4 | 29% | 1% | 13 | Search HUMANIZED+MOUSE | Search HUMANIZED+MOUSE |
9 | BLT MICE | 4 | 67% | 0% | 4 | Search BLT+MICE | Search BLT+MICE |
10 | ASIALO GM 1 | 4 | 75% | 0% | 3 | Search ASIALO+GM+1 | Search ASIALO+GM+1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HU MOUSE | 115 | 77% | 7% | 78 |
2 | HUMAN IMMUNE SYSTEM | 71 | 52% | 8% | 95 |
3 | SCID IL2R GAMMANULL MICE | 56 | 73% | 4% | 43 |
4 | RAG2 GAMMA C MICE | 33 | 83% | 2% | 19 |
5 | SCID HU MOUSE | 25 | 23% | 8% | 95 |
6 | RAG HU MICE | 20 | 100% | 1% | 9 |
7 | BLT MICE | 19 | 63% | 2% | 19 |
8 | HU MICE | 19 | 71% | 1% | 15 |
9 | REGULATORY PROTEIN ALPHA | 12 | 53% | 1% | 16 |
10 | PBL SCID MICE | 12 | 23% | 4% | 45 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Humanized mice for immune system investigation: progress, promise and challenges | 2012 | 112 | 123 | 64% |
Current advances in humanized mouse models | 2012 | 50 | 79 | 72% |
New generation humanized mice for virus research: Comparative aspects and future prospects | 2013 | 36 | 147 | 51% |
Human Hemato-Lymphoid System Mice: Current Use and Future Potential for Medicine | 2013 | 41 | 198 | 41% |
Humanized mice in translational biomedical research | 2007 | 460 | 125 | 35% |
New challenges in modern vaccinology | 2015 | 2 | 40 | 35% |
SCID mouse models of human stem cell engraftment | 1998 | 161 | 105 | 41% |
Generation of improved humanized mouse models for human infectious diseases | 2014 | 9 | 147 | 46% |
Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement | 2011 | 43 | 53 | 66% |
Human immune responses and potential for vaccine assessment in humanized mice | 2013 | 10 | 46 | 74% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VIRUS PATHOGENESIS | 2 | 67% | 0.2% | 2 |
2 | BILL MELINDA GATES FDN GRAND CHALLENGES GLOBAL | 1 | 100% | 0.2% | 2 |
3 | CLIN GYNECOL OBSTET ST HEDWIG | 1 | 50% | 0.2% | 2 |
4 | VIRAL CONTROL | 1 | 50% | 0.2% | 2 |
5 | NOMURA PROJECT | 1 | 40% | 0.2% | 2 |
6 | UNIT HUMAN DIS MODELS | 1 | 27% | 0.3% | 3 |
7 | INTERDISCIPLINARY GRP INFECT DIS | 1 | 15% | 0.4% | 5 |
8 | IMMUNOL AMSTERDAM | 1 | 33% | 0.2% | 2 |
9 | VIROLBUNKYO KU | 1 | 33% | 0.2% | 2 |
10 | AMC UVA | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000131554 | LEUKEMIA STEM CELLS//EXPT THER EUT TRANSLAT ONCOL PROGRAM//LEUKEMIC STEM CELL |
2 | 0.0000111708 | FP3//HOLLOW FIBRE ASSAY//AFFILIATED ZHUJI HOSP |
3 | 0.0000069513 | EX VIVO EXPANSION//CYTOKINE MEDIATED EXPANSION//AFT024 |
4 | 0.0000057319 | EXPTL IMMUNOL UNIT//BN 52080//GLUCOCORTICOIDS SYNTHETIC |
5 | 0.0000048738 | IN UTERO TRANSPLANTATION//FETAL GENE THERAPY//INUTERO TRANSPLANTATION |
6 | 0.0000041139 | SURGICAL ORTHOTOPIC IMPLANTATION//ORTHOTOPIC IMPLANTATION//ORTHOTOPIC MOUSE MODELS |
7 | 0.0000040848 | AUSTRALIAN VACCINE DEV TUMOUR IMMUNOL//EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 1//JOINT ONCOL PROGRAM |
8 | 0.0000038834 | VDJ RECOMBINATION//RAG2//RAG1 |
9 | 0.0000037683 | SHPS 1//BIOSIGNAL SCI//CD47 |
10 | 0.0000034060 | TRANSPLACENTAL MUTAGENICITY//ANTITUMOR PREPARATIONS//CANA3DTPA |